Evidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemia
- PMID: 21172017
- PMCID: PMC3016268
- DOI: 10.1186/1756-0500-3-341
Evidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemia
Abstract
Background: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western population. Although genetic factors are considered to contribute to CLL etiology, at present genomic aberrations identified in CLL are limited compared with those identified in other types of leukemia, which raises the question of the degree of genetic influence on CLL. We performed a high-resolution genome scanning study to address this issue.
Findings: Using the restriction paired-end-based Ditag Genome Scanning technique, we analyzed three primary CLL samples at a kilobase resolution, and further validated the results in eight primary CLL samples including the two used for ditag collection. From 51,632 paired-end tags commonly detected in the three CLL samples representing 5% of the HindIII restriction fragments in the genomes, we identified 230 paired-end tags that were present in all three CLL genomes but not in multiple normal human genome reference sequences. Mapping the full-length sequences of the fragments detected by these unmapped tags in seven additional CLL samples confirmed that these are the genomic aberrations caused by small insertions and deletions, and base changes spreading across coding and non-coding regions.
Conclusions: Our study identified hundreds of loci with insertion, deletion, base change, and restriction site polymorphism present in both coding and non-coding regions in CLL genomes, indicating the wide presence of small genomic aberrations in chronic lymphocytic leukemia. Our study supports the use of a whole genome sequencing approach for comprehensively decoding the CLL genome for better understanding of the genetic defects in CLL.
Figures

Similar articles
-
Genetic features of B-cell chronic lymphocytic leukemia.Rev Clin Exp Hematol. 2000 Mar;4(1):48-72. doi: 10.1046/j.1468-0734.2000.00003.x. Rev Clin Exp Hematol. 2000. PMID: 11486330 Review.
-
Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.BMC Genomics. 2017 Mar 16;18(1):236. doi: 10.1186/s12864-017-3617-6. BMC Genomics. 2017. PMID: 28302063 Free PMC article.
-
BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.Oncol Lett. 2016 May;11(5):3240-3246. doi: 10.3892/ol.2016.4388. Epub 2016 Mar 29. Oncol Lett. 2016. PMID: 27123097 Free PMC article.
-
Scanning the human genome at kilobase resolution.Genome Res. 2008 May;18(5):751-62. doi: 10.1101/gr.068304.107. Epub 2008 Feb 21. Genome Res. 2008. PMID: 18292219 Free PMC article.
-
Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.Cancer Genet. 2013 Mar;206(3):49-62. doi: 10.1016/j.cancergen.2013.01.003. Epub 2013 Mar 24. Cancer Genet. 2013. PMID: 23531595 Review.
Cited by
-
AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome.PLoS One. 2018 Nov 8;13(11):e0206620. doi: 10.1371/journal.pone.0206620. eCollection 2018. PLoS One. 2018. PMID: 30408048 Free PMC article.
-
Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study.Ther Adv Hematol. 2013 Jun;4(3):157-71. doi: 10.1177/2040620713478629. Ther Adv Hematol. 2013. PMID: 23730494 Free PMC article.
References
-
- Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639–1647. doi: 10.1084/jem.194.11.1639. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources